Risks of hypertension and thromboembolism in patients receiving bevacizumab with chemotherapy for colorectal cancer: A systematic review and meta-analysis.
Cancer Med
; 12(24): 21579-21591, 2023 12.
Article
in En
| MEDLINE
| ID: mdl-38069531
Full text:
1
Database:
MEDLINE
Main subject:
Colorectal Neoplasms
/
Colonic Neoplasms
/
Venous Thromboembolism
/
Hypertension
Type of study:
Systematic_reviews
Limits:
Humans
Language:
En
Journal:
Cancer Med
Year:
2023
Type:
Article
Affiliation country:
United States